Latest Production Facilities News

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

IDT Australia has signed a memorandum with NASDAQ-listed Gelteq to establish a dedicated gel-based product manufacturing facility, marking a strategic expansion in pharmaceutical delivery technologies.

Hazer Group has signed a non-binding MOU with UK’s EnergyPathways to explore a large-scale clean hydrogen facility integrated with the Marram Energy Storage Hub in northwest England.

DroneShield is investing $13 million to significantly expand its R&D and manufacturing footprint, aiming to boost annual production capacity nearly fivefold by the end of 2026.

Athena Resources has partnered with Warradarge Energy and Fenix Resources to launch the Mid West Green Iron Project, aiming to produce sustainable green iron using ultra-high-grade magnetite and renewable hydrogen in Western Australia.

Green Critical Minerals’ proprietary VHD graphite heat sink outperforms traditional materials in computational tests, promising enhanced thermal management for high-power microchips in data centres.

BPH Global has launched a focused R&D collaboration with Temasek Polytechnic to develop seaweed-based bio-stimulants aimed at boosting growth and yields in Southeast Asia's oil palm and rice sectors. Early talks are also underway for a production facility in Indonesia to commercialize these innovations.

Papyrus Australia has successfully expanded its banana fibre technology to produce boards and flat paper products, while advancing a promising joint venture in Vietnam for high-volume production.

Firebird Metals has reported promising lab-scale results for its lithium manganese iron phosphate cathode material, showing a significant energy density improvement over standard LFP. The company is moving towards pilot-scale production and global commercialisation.

Zeotech Limited’s Preliminary Feasibility Study (PFS) for its AusPozz™ Project reveals a robust business case for Australia’s first metakaolin production facility, promising strong financial returns and significant carbon emission reductions.

Lynch Group reports robust FY25 trading results, driven by strong Australian and Chinese markets, and sets optimistic full-year revenue and earnings guidance.

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.